• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC; FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC; FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Catalog Number C-UTLM-701J-RSC-ABRM-HC-RD
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Code Available (3191)
Event Date 02/03/2020
Event Type  malfunction  
Manufacturer Narrative
Device name: cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter set.Rpn: reported as: c-utlm-701j-abrm-hc-rd, but more likely to be c-utlm-701j-rsc-abrm-hc-rd based on hub detail.(b)(6).Occupation: clinical products advisor.Patient code: no code available: patient unexpectedly required "excessive interventions" due to inadequate treatment resulting from the patient not being able to receive the proper medication/fluids due to the leak.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.
 
Event Description
It was reported that the hub of a cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter was leaking.The line was inserted into the patient's subclavian vein in another facility before the patient was transferred to the provider that initiated the complaint.The line was used for administration of inotropes, fluids, and sedation treatments.It was reported that "while attending to [the] patient, it was observed [that the] patient was requiring significantly increased amounts of inotrope support running through mid lumen (blue hub)" of the device.The patient's treatment was altered as necessary as the infusions were transferred to other access ports until the patient stabilized and no longer required "excessive interventions".Additional information regarding the device has been requested but is unavailable at this time.No other adverse effects have been reported for this incident.
 
Manufacturer Narrative
This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Additional information regarding the device was received on 17mar2020.A bd smartsite needleless connector was connected to the hub.Nothing was being infused at the time.
 
Event Description
No additional information regarding patient and/or event details has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unchanged or unavailable.Additional information: product identifier, d1, d4 - rpn.D1- device name: cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter set.Investigation evaluation.It was reported that a cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter set (c-utlm-701j-rsc-abrm-hc-rd) from an unknown lot leaked at the blue hub.It is unknown how long the device was in place before the leakage was noted.Cook became aware of this event on 13feb2020 upon being notified by the clinical products advisor from waikato hospital.The patient reportedly experienced no adverse effects as a result of this incident.A review of documentation including the complaint history, instructions for use (ifu) and quality control, as well as a visual inspection and functional test of the returned device was conducted during the investigation.One used 7fr 20cm triple-lumen central venous catheter was returned for evaluation.Biological matter was found to be present throughout the device.The blue hub is cracked through the number ¿2¿ stamped on the hub.A leak test was performed and confirmed leakage at the blue hub.Non-cook needleless connectors were attached to the red and white hubs.The connector could not be removed from the red hub.The connector was removed from the white hub and the lumen was flushed with no incident.Additionally, a document-based investigation evaluation was performed.It was concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.The risks associated with these devices are acceptable when weighed against the benefits.A review of the device history record could not be completed due to lack of lot information from the user facility.There is no evidence to suggest that nonconforming product exists in house or in the field.The instructions for use (ifu), provides the following information to the user related to the reported failure mode: warnings.The safe and effective use of central venous catheters with power injector pressures (safety cut-off) set above 325 psi has not been established.Do not power inject if maximum injection rate cannot be verified to meet limit of 10 ml/sec.To safely use catheters with a power injector, the technician/healthcare professional must verify prior to use that the maximum safety cut-off pressure limit is set at or below 325 psi and that the maximum flow rate is at or below 10 ml/sec.Power injection procedure.Warning: failure to ensure patency of the catheter lumen prior to injection may result in catheter failure.How supplied.Upon removal from package, inspect the product to ensure no damage has occurred.Based on the information provided, examination of the returned product and the results of our investigation, a definitive root cause could not be established.A capa is currently open to address the issue of cracked hubs in this product line.The appropriate personnel have been notified.We will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key9757018
MDR Text Key181956190
Report Number1820334-2020-00468
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
K081113
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup,Followup
Report Date 05/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberC-UTLM-701J-RSC-ABRM-HC-RD
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2020
Date Manufacturer Received04/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BD SMARTSITE NEEDLELESS CONNECTOR
-
-